PharmaShots | Incisive News in 3 Shots

Subscribe Now

Existing Collaboration

Synaffix Expands its Existing Collaboration with ADC Therapeutics to Explore Two Additional Programs

Synaffix Expands its Existing Collaboration with ADC Therapeutics to Explore Two Additional Programs

July 24, 2020

Curis Amends its Existing Collaboration with Aurigene for the Development and Commercialization of CA-170

Curis Amends its Existing Collaboration with Aurigene for the Development and Commercialization of CA-170

February 7, 2020

Regeneron Expands its Existing Collaboration with HHS'BARDA to Develop Antibody Therapies for Coronavirus

Regeneron Expands its Existing Collaboration with HHS'BARDA to Develop Antibody Therapies for Coronavirus

February 5, 2020

AbbVie Enters into an Exclusive Option and License Agreement for HPN217 and Expands its Existing Collaboration with Harpoon Therapeutics

AbbVie Enters into an Exclusive Option and License Agreement for HPN217 and Expands its Existing Collaboration with Harpoon Therap...

November 21, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us